Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Microb Pathog ; 127: 220-224, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30529428

RESUMO

The aim of this study was to evaluate the resistance of Rhamdia quelen (silver catfish) to Aeromonas hydrophila infection after treatment with pure and nanoencapsulated forms either terpinen-4-ol, thymol, or carvacrol and the effects of these treatments on fish metabolic responses. After A. hydrophila inoculation, fish were treated with 30 min daily baths for 6 consecutive days with terpinen-4-ol, thymol, or carvacrol in their pure or nanoencapsulated forms at concentrations of 5, 10, 15 or 25 mg L-1. A positive control group, negative control group and saline group were also included. Survival was evaluated at the end of treatment for six consecutive days. Muscle and liver were collected to determine glucose and lactate levels. The fish treated with the nanoencapsulated form of the compounds had a high survival rate, similar to saline group and negative control groups. The carvacrol, thymol and terpinen-4-ol nanoencapsulated forms improved survival of silver catfish infected with A. hydrophila. Muscle and liver glucose and lactate levels are not indicated as biomarkers because they did not present any correlation between the metabolic state of the fish and the bacterial infection.


Assuntos
Aeromonas hydrophila/crescimento & desenvolvimento , Anti-Infecciosos/administração & dosagem , Doenças dos Peixes/tratamento farmacológico , Glucose/análise , Infecções por Bactérias Gram-Negativas/veterinária , Ácido Láctico/análise , Animais , Peixes-Gato , Cimenos , Doenças dos Peixes/microbiologia , Doenças dos Peixes/patologia , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/microbiologia , Infecções por Bactérias Gram-Negativas/patologia , Fígado/patologia , Monoterpenos/administração & dosagem , Músculos/patologia , Análise de Sobrevida , Terpenos/administração & dosagem , Timol/administração & dosagem , Resultado do Tratamento
2.
Microb Pathog ; 124: 116-121, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30138756

RESUMO

This study evaluated the antibacterial activity of Origanum majorana essential oil (EOM) and nanocapsules of this oil (NOM) in silver catfish, Rhamdia quelen, infected with Aeromonas hydrophila, and addressed their effects on silver catfish hematological and metabolic parameters. Fish were inoculated with A. hydrophila (360 µL, at a concentration of 1.5 × 109 CFU mL-1) and submitted to 1 h daily baths with EOM (0 (control), 20 or 30 µL L-1), NOM (0 (control), 5 or 10 µL L-1) or a positive control containing florfenicol (30 µL L-1) called group Maxflor® for five consecutive days. All treatments improved the survival rate of the infected fish, but we suggest the treatment of A. hydrophila infections through daily baths with 20 µL L-1 EOM or 5 µL L-1 NOM for five consecutive days as these were the lowest effective concentrations tested. Silver catfish treated with EOM and NOM had higher lymphocyte levels, indicating stimulation of the immune system in these fish. The lowest liver glucose level was found in the group treated with the lowest concentration of NOM, and the lactate values in the liver and muscle of all groups were within the normal values reported for this species. In addition, nanocapsules required much less EOM to elicit effective antibacterial treatment.


Assuntos
Aeromonas hydrophila/efeitos dos fármacos , Peixes-Gato , Doenças dos Peixes/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/veterinária , Fatores Imunológicos/administração & dosagem , Óleos Voláteis/administração & dosagem , Origanum/química , Animais , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/microbiologia , Fatores Imunológicos/isolamento & purificação , Óleos Voláteis/isolamento & purificação , Análise de Sobrevida , Resultado do Tratamento
3.
Microb Pathog ; 100: 170-178, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27544324

RESUMO

Infections due to microbial biofilm formation on the surface of catheters and other medical devices are constantly reported as a major cause of morbidity and mortality in patients admitted to hospitals. Furthermore, sessile cells are more resistant to phagocytosis and most antimicrobial, which complicates the treatment of such infections. Researches aimed at new antimicrobial originating mainly from plants have increased in recent years and the development of new strategies for their release is critical in combating the formation of biofilms. Geranium oil (GO) has proven antimicrobial activity. Because of this, the aim of this study was to develop nanoemulsions containing this oil (NEG) and evaluate its activity after the biofilm formation of Candida albicans, Candida tropicalis, Candida glabrata, and Candida krusei in hospital medical supplies. For quantification of the biofilm, crystal violet, total protein, and ATP-bioluminescence assays were used. The results revealed that GO and NEG showed lower MIC for C. albicans and C. tropicalis. The biofilms formed by different species of Candida on the surfaces of polyethylene and polyurethane were quantified. GO and NEG significantly inhibited the formation of biofilms in all species tested on the surfaces of polyethylene. However, NEG antibiofilm has had better activity than GO for C. albicans, C. tropicalis and C. glabrata, according to the surface potential analysis by atomic force microscopy (AFM). The analysis of the biofilm formation on the polyethylene surface by ATP-bioluminescence and CFU showed similar results. In both methods the formation of biofilm in the catheter occurred in greater quantity for C. albicans and C. tropicalis. GO did not significantly inhibit the formation of biofilms only in C. krusei, although NEG significantly increased this activity GO in all species tested when compared to the control training biofilm. The following study shows that the development of NEG may become an effective alternative to reduce the adhesion of microorganisms and prevent infections resulting from the use of some hospital medical materials.


Assuntos
Antifúngicos/farmacologia , Biofilmes/efeitos dos fármacos , Candida/efeitos dos fármacos , Equipamentos e Provisões/microbiologia , Pelargonium/química , Extratos Vegetais/farmacologia , Antifúngicos/isolamento & purificação , Candida/fisiologia , Emulsões/farmacologia , Hospitais , Testes de Sensibilidade Microbiana , Extratos Vegetais/isolamento & purificação
4.
J Invertebr Pathol ; 112(2): 105-7, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23220240

RESUMO

The honeybee disease American foulbrood (AFB) is a serious problem since its causative agent (Paenibacillus larvae) has become increasingly resistant to conventional antibiotics. One of the feasible alternative treatments being used for control of this disease are plants extracts. The aim of the present work was to evaluate the effect of crude extract and fractions of Scutia buxifolia against six Paenibacillus species, including P. larvae, and its potential use for the control of AFB. In vitro activity of S. buxifolia samples against Paenibacillus species were evaluated by the disk diffusion and microdilution methods, and the minimal inhibitory concentration (MIC) were also determined. All Paenibacillus species were sensitive to crude extract and fractions of S. buxifolia. The dichloromethane (DC) fraction showed the better MIC (1.56 mg/mL), followed by ethyl acetate (EtAc) (6.25 mg/mL), n-butanol (BuOH) (25 mg/mL) and Crude extract (CE) (50 mg/mL). Toxic effect of S. buxifolia crude extracts and fractions against bees were also evaluated by the spraying application method of the same concentrations of MICs. The samples tested showed no toxic effects for the bees after 15 days of observation. These results are first time described for this species and showed that S. buxifolia presented a important activity against Paenibacillus species and proved to be a natural alternative for the prevention/control of AFB.


Assuntos
Anti-Infecciosos/farmacologia , Abelhas/microbiologia , Infecções por Bactérias Gram-Positivas/veterinária , Viabilidade Microbiana/efeitos dos fármacos , Paenibacillus/efeitos dos fármacos , Extratos Vegetais/farmacologia , Rhamnaceae , Animais , Anti-Infecciosos/química , Anti-Infecciosos/toxicidade , Abelhas/efeitos dos fármacos , Fracionamento Químico , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Estimativa de Kaplan-Meier , Larva/efeitos dos fármacos , Larva/microbiologia , Longevidade/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Paenibacillus/patogenicidade , Extratos Vegetais/química , Extratos Vegetais/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA